Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer

NCT06546969 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Cancer
Cholangiocarcinoma

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Durvalumab
RADIATION: Spatially Fractionated RT
DEVICE: Deep Hyperthermia

Sponsor

University of Maryland, Baltimore